Plans are finalized for the upcoming Neurofibromatosis Symposium to be held in the Bradley Lecture Center of the Children’s Harbor Building at Children’s of Alabama on Saturday, August 27 th. This ...

This month, I’d like to address an issue that often arises in the minds of parents whose children have been newly diagnosed with NF1. These parents often ask when they should be concerned about an ...

Neurofibromatosis type 1 (NF1) is a hereditary condition arising from mutations in the NF1 gene, which encodes neurofibromin—a key regulator of cellular signalling and neural development. Children ...

Almost half of adults and children with neurofibromatosis type 1 (NF1) responded to the investigational MEK inhibitor mirdametinib, a large multicenter study of the rare condition showed. Overall, 53 ...

For NF Awareness Month this May, nonprofit organization the Children’s Tumor Foundation is launching a new campaign aimed at neurofibromatosis (NF). This rare disorder, also known as schwannomatosis, ...

Neurofibromatosis is a genetic disorder that causes tumors to grow on nerve tissue throughout the body. NF can lead not only to disabling pain, but also to disfigurement, cancer and even death.

"When one tumor is removed, it's like another pops up," says Michele Holbrook, who is raising awareness of neurofibromatosis for the Children's Tumor Foundation Craig Warga for Children's Tumor ...

(NEW YORK, NY and BRUSSELS, BELGIUM) - June 17, 2024 - The 2024 Global NF Conference, organized by the Children’s Tumor Foundation (CTF) and the European NF Group, and hosted by Children's Tumor ...

For the first time, the Empire State Building and the London Eye join internationally recognizable landmarks glowing blue and green NEW YORK, May 17, 2023 /PRNewswire/ -- The Children's Tumor ...

NEW YORK--(BUSINESS WIRE)--Colbeck Capital Management, a leading middle-market private credit firm focused on strategic lending, today announced its continued support of the Children’s Tumor ...